About: Anne Moscona

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Anne Moscona Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

American pediatrician and virologist

Attributes	Values
rdf:type	Item
owl:sameAs	Anne Moscona
description	American pediatrician and virologist (en)
rdfs:label	Anne Moscona (en)
skos:prefLabel	Anne Moscona (en)
name	Anne Moscona (en)
LinkedIn personal profile ID	wds:Q113032251-7643c9c1-4658-180b-0248-b7feca012717
LinkedIn personal profile ID	dr-anne-moscona-138a031b
given name	wds:Q113032251-270492db-4d2a-05ee-5112-fb44bef0d9ac
given name	Anne
instance of	wds:Q113032251-F8DA18B0-98A5-44BC-A3B7-194F55FA69C2
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q113032251-CF8733DA-6821-48C3-A731-EB8F58F9DAEA
Google Knowledge Graph ID	http://g.co/kg/g/11gd2jt3fq
Google Knowledge Graph ID	/g/11gd2jt3fq
Google Scholar author ID	wds:Q113032251-c5da1330-4957-4fe1-683a-1eadc167c259
Google Scholar author ID	2Ay8qC4AAAAJ
employer	wds:Q113032251-533D68A4-DD8C-4868-927B-8AD80A8E7639
place of birth	wds:Q113032251-ECB9CBED-853D-4AB9-9379-4D330AA5882C
sex or gender	wds:Q113032251-d21c68d4-42c6-ca19-4013-6c9e0177547a
father	wds:Q113032251-b23cd91b-4651-2aac-c53b-68a78eab29ba
educated at	wds:Q113032251-2564260F-EE59-4D3C-BADF-A2E2E68FF152 wds:Q113032251-36FE7485-70B2-40C3-8F93-0395B0EC3F70
family name	wds:Q113032251-d08442f6-4134-bf5d-dccf-03c1bcc714a7
employer	Columbia University Irving Medical Center
place of birth	Chicago
sex or gender	female organism
father	Aron Moscona
educated at	Columbia University Vagelos College of Physicians and Surgeons Harvard College
family name	Moscona
ORCID iD	wds:Q113032251-c202e6e5-4a6d-d722-7d9f-88f395de77a1
ORCID iD	https://orcid.org/0000-0002-1796-8320
ORCID iD	0000-0002-1796-8320
is about of	Anne Moscona https://www.wikidata.org/wiki/Special:EntityData/Q113032251 Anne Moscona
is author of	Oseltamivir resistance--disabling our influenza defenses Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus Neuraminidase inhibitors for influenza A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites. Medical management of influenza infection. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir). A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo A broad-spectrum antiviral targeting entry of enveloped viruses Regulation of paramyxovirus fusion activation: the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state. Oseltamivir-resistant influenza? Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy. Viral entry inhibitors targeted to the membrane site of action. Kinetic dependence of paramyxovirus entry inhibition. Global transmission of oseltamivir-resistant influenza Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005. Unity in diversity: shared mechanism of entry among paramyxoviruses Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease The cell biology of acute childhood respiratory disease: therapeutic implications Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity. A daring treatment and a successful outcome: the need for targeted therapies for pediatric respiratory viruses. Interaction between the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Human Parainfluenza Virus Type III Regulates Viral Growth In Vivo Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue Identification of a region in the stalk domain of the nipah virus receptor binding protein that is critical for fusion activation Measles virus fusion machinery activated by sialic acid binding globular domain The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein Bronchiolitis: too-familiar yet too-mysterious disease of childhood Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II RSV vaccine: Beating the virus at its own game A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity Fatal measles virus infection prevented by brain-penetrant fusion inhibitors A three-dimensional model of human lung development and disease from pluripotent stem cells. News about influenza B drug resistance that cannot be ignored Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides. Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates. Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus. Effects of single α-to-β residue replacements on recognition of an extended segment in a viral fusion protein In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19 Dual Inhibition of Human Parainfluenza Type 3 and Respiratory Syncytial Virus Infectivity with a Single Agent Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation. Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonance Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain Antiviral Lipopeptide-Cell Membrane Interaction Is Influenced by PEG Linker Length. In vivo antiviral host response to SARS-CoV-2 by viral load, sex, and age Features of Circulating Parainfluenza Virus Required for Growth in Human Airway. Erratum for Gui et al., Electron Tomography Imaging of Surface Glycoproteins on Human Parainfluenza Virus 3: Association of Receptor Binding and Fusion Proteins before Receptor Engagement Measles fusion machinery is dysregulated in neuropathogenic variants Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software